New therapies for MND

      Motor neuron disease (MND) is one of the 3 commonest adult onset neurodegenerative disorders with a life-time risk of approximately 1 in 400. Death in most patients results from neuromuscular respiratory failure. The heterogeneity and complexity of MND has posed a challenge for neuroprotective therapy development. This lecture will cover 4 areas of topical interest.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect